These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 17157102)

  • 21. Management of missed abortion: comparison of medical treatment with either mifepristone + misoprostol or misoprostol alone with surgical evacuation. A multi-center trial in Copenhagen county, Denmark.
    Grønlund A; Grønlund L; Clevin L; Andersen B; Palmgren N; Lidegaard Ø
    Acta Obstet Gynecol Scand; 2002 Nov; 81(11):1060-5. PubMed ID: 12421175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The efficacy and acceptability of mifepristone medical abortion with home administration misoprostol provided by private providers linked with the hospital: a prospective study of 433 patients].
    Faucher P; Baunot N; Madelenat P
    Gynecol Obstet Fertil; 2005 Apr; 33(4):220-7. PubMed ID: 15894206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Consistency of medical abortion efficacy from 5 through 14 weeks' gestation.
    Garbin O; Vayssiere C; Bettahar-Lebugle K; Nisand I
    Eur J Obstet Gynecol Reprod Biol; 2006 Nov; 129(1):36-40. PubMed ID: 16325992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medical management of early pregnancy failure: efficacy.
    Chen BA; Creinin MD
    Semin Reprod Med; 2008 Sep; 26(5):411-22. PubMed ID: 18825609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increasing women's choices in medical abortion: a study of misoprostol 400 microg swallowed immediately or held sublingually following 200 mg mifepristone.
    Akin A; Dabash R; Dilbaz B; Aktün H; Dursun P; Kiran S; Aksan G; Doğan B; Winikoff B
    Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):169-75. PubMed ID: 19565414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized comparison of misoprostol 6 to 8 hours versus 24 hours after mifepristone for abortion.
    Creinin MD; Fox MC; Teal S; Chen A; Schaff EA; Meyn LA;
    Obstet Gynecol; 2004 May; 103(5 Pt 1):851-9. PubMed ID: 15121556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preference and acceptability of oral versus vaginal administration of misoprostol in medical abortion with mifepristone.
    Arvidsson C; Hellborg M; Gemzell-Danielsson K
    Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):87-91. PubMed ID: 16260342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early medical abortion: a new regimen up to 49 days' gestation.
    Ashima T; Vinita A; Shalini R
    Aust N Z J Obstet Gynaecol; 2005 Apr; 45(2):137-9. PubMed ID: 15760315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mifepristone medical abortion in Albania: results from a pilot clinical research study.
    Bracken H; Gliozheni O; Kati K; Manoku N; Moisiu R; Shannon C; Tare V; Tasha I; Winikoff B;
    Eur J Contracept Reprod Health Care; 2006 Mar; 11(1):38-46. PubMed ID: 16546815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period.
    Middleton T; Schaff E; Fielding SL; Scahill M; Shannon C; Westheimer E; Wilkinson T; Winikoff B
    Contraception; 2005 Nov; 72(5):328-32. PubMed ID: 16246656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaginal vs. sublingual misoprostol with mifepristone for cervical priming in second-trimester abortion by dilation and evacuation: a randomized clinical trial.
    Carbonell JL; Gallego FG; Llorente MP; Bermudez SB; Sala ES; González LV; Texido CS
    Contraception; 2007 Mar; 75(3):230-7. PubMed ID: 17303495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are two doses of misoprostol after mifepristone for early abortion better than one?
    Coyaji K; Krishna U; Ambardekar S; Bracken H; Raote V; Mandlekar A; Winikoff B
    BJOG; 2007 Mar; 114(3):271-8. PubMed ID: 17217359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of late intrauterine death using a combination of mifepristone and misoprostol--experience of two regimens.
    Fairley TE; Mackenzie M; Owen P; Mackenzie F
    Eur J Obstet Gynecol Reprod Biol; 2005 Jan; 118(1):28-31. PubMed ID: 15596268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility and effectiveness of unintended pregnancy prevention with low-dose mifepristone combined with misoprostol before expected menstruation.
    Li CL; Chen DJ; Deng YF; Song LP; Mo XT; Liu KJ
    Hum Reprod; 2015 Dec; 30(12):2794-801. PubMed ID: 26405260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical study of terminating biochemical pregnancy and early clinical pregnancy with mifepristone and misoprostol].
    Li CL; Wei M; Fu MF; Li M
    Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):542-5. PubMed ID: 17983494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multicenter trial of a simplified mifepristone medical abortion regimen.
    Shannon CS; Winikoff B; Hausknecht R; Schaff E; Blumenthal PD; Oyer D; Sankey H; Wolff J; Goldberg R
    Obstet Gynecol; 2005 Feb; 105(2):345-51. PubMed ID: 15684163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medical management for termination of second and third trimester pregnancies: a comparison of strategies.
    De Heus R; Graziosi GC; Christiaens GC; Bruinse HW; Mol BW
    Eur J Obstet Gynecol Reprod Biol; 2004 Sep; 116(1):16-21. PubMed ID: 15294361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Misoprostol-only versus mifepristone plus misoprostol in induction of labor following intrauterine fetal death.
    Väyrynen W; Heikinheimo O; Nuutila M
    Acta Obstet Gynecol Scand; 2007; 86(6):701-5. PubMed ID: 17520402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association between serum progesterone and outcome of medical management of early fetal demise: a pilot study.
    Banerjee AK; Emembolu JO; Habiba M
    J Obstet Gynaecol; 2013 May; 33(4):384-6. PubMed ID: 23654321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Having an abortion using mifepristone and home misoprostol: a qualitative analysis of women's experiences.
    Fielding SL; Edmunds E; Schaff EA
    Perspect Sex Reprod Health; 2002; 34(1):34-40. PubMed ID: 11990637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.